The presumed vice-presidential candidate gets a mixed review on science funding and attitudes.
The Nutshell
Daily News Roundup
Most Recent
Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
The presidential bioethics brain trust unveils its draft recommendations on the use of whole genome sequencing in clinical care and research.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
After years of complaints, the European Commission proposes ways to fix its system in an effort to reinvigorate research on the continent.
Subjects
- cell & molecular biology
- clinical trials
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
